BREAST CANCER RESEARCH: UC-Irvine Receives $2.2M from Avon
UC-Irvine has been selected to receive a $2.2 million gift from the Avon Breast Cancer Crusade, which will allow the institution to continue research on genetic factors of the disease and expand treatment programs to low-income and minority women, the Los Angeles Times reports. UCI was one of five research institutions selected by Avon to split the $14 million grant. Dr. Thomas Cesario, dean of UCI Medical School, said, "It is a very special award. It's particularly significant because ... we were selected by Avon among 125 American medical schools." One of 37 nationally designated comprehensive cancer centers, UCI has a strong research program and a commitment to serving low-income women. Senior Manager of Avon's Breast Cancer Crusade Patricia Sterling said, "We were looking for centers that had a demonstrated commitment to medically underserved women. We wanted an academic health center ... with impeccable credentials and a faculty that included women physicians and scientists." UCI plans to use the funding to provide free or low-cost services, including counseling, transportation, home care, wound care prostheses and genetic testing (3/8).
This is part of the California Healthline Daily Edition, a summary of health policy coverage from major news organizations. Sign up for an email subscription.